Rockefeller Capital Management L.P. Sells 2,602 Shares of Cardinal Health, Inc. $CAH

Rockefeller Capital Management L.P. trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH) by 17.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,164 shares of the company’s stock after selling 2,602 shares during the period. Rockefeller Capital Management L.P.’s holdings in Cardinal Health were worth $2,500,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Redhawk Wealth Advisors Inc. grew its position in Cardinal Health by 0.5% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 9,255 shares of the company’s stock worth $1,902,000 after buying an additional 48 shares in the last quarter. HF Advisory Group LLC raised its holdings in Cardinal Health by 0.9% in the 4th quarter. HF Advisory Group LLC now owns 5,227 shares of the company’s stock valued at $1,074,000 after acquiring an additional 49 shares in the last quarter. Hillsdale Investment Management Inc. lifted its position in shares of Cardinal Health by 0.9% during the 4th quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock valued at $1,184,000 after acquiring an additional 50 shares during the period. Generali Asset Management SPA SGR lifted its position in shares of Cardinal Health by 11.0% during the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock valued at $105,000 after acquiring an additional 51 shares during the period. Finally, Stephens Inc. AR grew its holdings in shares of Cardinal Health by 0.9% during the 4th quarter. Stephens Inc. AR now owns 5,951 shares of the company’s stock worth $1,223,000 after purchasing an additional 52 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Shares of CAH stock opened at $236.03 on Tuesday. Cardinal Health, Inc. has a fifty-two week low of $137.75 and a fifty-two week high of $240.93. The stock’s fifty day moving average price is $206.52 and its two-hundred day moving average price is $210.66. The company has a market cap of $55.28 billion, a PE ratio of 36.09, a P/E/G ratio of 1.30 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The company had revenue of $60.94 billion during the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the firm earned $2.35 EPS. Cardinal Health’s revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be paid a dividend of $0.5158 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health’s payout ratio is presently 31.19%.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Weiss Ratings cut Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Robert W. Baird set a $248.00 price objective on shares of Cardinal Health in a research report on Friday, May 1st. Wells Fargo & Company reduced their price objective on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating on the stock in a research note on Friday, May 1st. Citigroup decreased their target price on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a report on Friday, May 1st. Finally, William Blair began coverage on shares of Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $246.93.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.